387 The SURPASS-5 trial, a 40-week study that enrolled 475 individuals with type 2 diabetes, examined the addition of tirzepatide (5 mg, 10 mg, or 15 mg once weekly) to insulin compared with insulin alone in patients treated with or without metformin
This isnt just a trial miss its a commercial positioning problem. u/equities_nerd42 r/wallstreetbets took the opposite view
You may have heard of Semaglutide before
Considering the established involvement of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and transforming growth factor-beta1 (TGF-1) in RA, this research aimed to assess efficacy and safety of L-carnitine as an adjunct therapy targeting these pathways
DZ: Data curation, Formal Analysis, Writing review and editing, Software
However, you should still notify your prescriber of both medications so they can monitor for gastrointestinal side effects and confirm the infection is responding appropriately to treatment
